AQR Capital Management’s GenMark Diagnostics, Inc GNMK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-42,087
| Closed | -$1.01M | – | 2338 |
|
|
2021
Q1 | $1.01M | Sell |
42,087
-87,842
| -68% | -$1.63M | ﹤0.01% | 1546 |
|
|
2020
Q4 | $1.9M | Buy |
129,929
+5,112
| +4% | +$67.8K | ﹤0.01% | 1189 |
|
|
2020
Q3 | $1.77M | Buy |
124,817
+65,920
| +112% | +$1.01M | ﹤0.01% | 1167 |
|
|
2020
Q2 | $866K | Buy |
+58,897
| New | +$598K | ﹤0.01% | 1515 |
|
|
2020
Q1 | – | Sell |
-43,420
| Closed | -$209K | – | 2214 |
|
|
2019
Q4 | $209K | Sell |
43,420
-82,446
| -66% | -$455K | ﹤0.01% | 2003 |
|
|
2019
Q3 | $763K | Buy |
125,866
+83,656
| +198% | +$522K | ﹤0.01% | 1606 |
|
|
2019
Q2 | $274K | Buy |
42,210
+30,403
| +257% | +$214K | ﹤0.01% | 1902 |
|
|
2019
Q1 | $84K | Buy |
+11,807
| New | +$77.8K | ﹤0.01% | 2143 |
|
|
2017
Q4 | – | Sell |
-23,204
| Closed | -$223K | – | 2295 |
|
|
2017
Q3 | $223K | Sell |
23,204
-16,649
| -42% | -$173K | ﹤0.01% | 2151 |
|
|
2017
Q2 | $471K | Buy |
39,853
+6,534
| +20% | +$83.5K | ﹤0.01% | 1912 |
|
|
2017
Q1 | $427K | Buy |
33,319
+17,901
| +116% | +$215K | ﹤0.01% | 1931 |
|
|
2016
Q4 | $189K | Buy |
+15,418
| New | +$183K | ﹤0.01% | 2159 |
|
|
2014
Q4 | – | Sell |
-12,094
| Closed | -$108K | – | 2666 |
|
|
2014
Q3 | $108K | Buy |
12,094
+400
| +3% | +$4.3K | ﹤0.01% | 2437 |
|
|
2014
Q2 | $158K | Sell |
11,694
-8,900
| -43% | -$92.9K | ﹤0.01% | 2413 |
|
|
2014
Q1 | $205K | Sell |
20,594
-2,800
| -12% | -$34.8K | ﹤0.01% | 2429 |
|
|
2013
Q4 | $311K | Hold |
23,394
| – | – | ﹤0.01% | 2275 |
|
|
2013
Q3 | $284K | Buy |
+23,394
| New | +$251K | ﹤0.01% | 2239 |
|
AQR Capital Management's GNMK Position: Q2 2021 in Review
AQR Capital Management sold out of GenMark Diagnostics, Inc (GNMK) in Q2 2021, closing a stake of 42,087 shares — an estimated $1.01M sold.
AQR Capital Management first reported a position in GNMK in Q3 2013 and held it in 17 quarters. The position peaked at $1.9M in Q4 2020. 0 funds tracked by Wall St. Rank hold GNMK as of Q2 2021.
- AQR Capital Management reported no remaining GenMark Diagnostics, Inc position as of Q2 2021 after selling out during the quarter.
- AQR Capital Management sold 42,087 GenMark Diagnostics, Inc shares in Q2 2021, an estimated $1.01M.
- AQR Capital Management first reported a position in GenMark Diagnostics, Inc in Q3 2013 and held it in 17 quarters.
- AQR Capital Management's GenMark Diagnostics, Inc position peaked at $1.9M in Q4 2020.
- 0 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q2 2021.
Based on AQR Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.